University of North Carolina Lineberger Comprehensive Cancer Center scientists have uncovered a potential therapeutic target for kidney cancers that have
Continue reading »Home » Brain Tumor »
New development in 3D super-resolution imaging gives insight on Alzheimer’s disease
Recent studies show that 40 percent of Americans over the age of 85 have Alzheimer’s disease, and that the disease
Continue reading »As brain extracts meaning from vision, study tracks progression of processing
Here’s the neuroscience of a neglected banana (and a lot of other things in daily life): whenever you look at
Continue reading »Scientists solve the case of the missing subplate, with wide implications for brain science
The disappearance of an entire brain region should be cause for concern. Yet, for decades scientists have calmly maintained that
Continue reading »‘Antifreeze’ molecules may stop and reverse damage from brain injuries: Role of N-acetylaspartate, a molecule that controls Amyloid build-up
The key to better treatments for brain injuries and disease may lie in the molecules charged with preventing the clumping
Continue reading »New therapeutic opportunity for the treatment of resistant malignant melanoma
A team of researchers led by Dr Pierre Close, WELBIO researcher at the ULiège GIGA Institute and Dr Francesca Rapino
Continue reading »Yellow fever: A new method for testing vaccine safety
Scientists from the Institut Pasteur, the CNRS and Sanofi Pasteur have recently developed a novel alternative method to animal testing
Continue reading »Targeting strategy may open door to better cancer drug delivery
Bioengineers may be able to use the unique mechanical properties of diseased cells, such as metastatic cancer cells, to help
Continue reading »How does alcohol influence the development of Alzheimer’s disease?
Research from the University of Illinois at Chicago has found that some of the genes affected by alcohol and inflammation
Continue reading »Precision medicine clinical trial releases new findings: NCI-MATCH data strengthen path forward for targeted cancer therapies
The National Cancer Institute’s Molecular Analysis for Therapy Choice (NCI-MATCH) trial, the largest precision medicine trial of its kind, has
Continue reading »